Long COVID in children and adolescents: a historical cohort study with a population-based control group from Iran.

Long COVID in children and adolescents: a historical cohort study with a population-based control group from Iran.

Publication date: Sep 30, 2024

After recovering from the acute phase of COVID-19, some of the infected children manifest long COVID symptoms. The present study aims to identify long COVID symptoms in children and adolescents admitted to hospitals in Bushehr, Iran, during 2021 to 2023, and compare them with the non-affected group. This historical cohort study with a population-based control group was conducted on 141 children and adolescents with COVID-19 hospitalized in Bushehr city hospitals and 141 non-affected peers. Out of 10 comprehensive health service centers in Bushehr city, 5 centers were selected by random sampling and the non-Covid-19 group was chosen from them (matched by gender and age with the affected group). The data were collected using the data recorded in the patients’ records, conducting telephone interviews and completing the prevalent long COVID symptom form. Data were analyzed using SPSS version 18. Descriptive statistics, Chi-square/Fisher’s exact tests, and stepwise logistic regression were used. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated, with p 

Open Access PDF

Concepts Keywords
Covid Adolescent
Hospitals Adolescents
Iran Case-Control Studies
Statistics Child
Child, Preschool
Children
Cohort Studies
Complications
COVID-19
COVID-19
Fatigue
Female
Hospitalization
Humans
Iran
Iran
Male
Pandemics
Post-Acute COVID-19 Syndrome
Post-COVID-19 syndrome
SARS-CoV-2

Semantics

Type Source Name
disease MESH Long COVID
disease MESH COVID-19
disease IDO symptom
pathway REACTOME Reproduction
disease MESH Infectious Diseases
drug DRUGBANK Coenzyme M
disease MESH depression
disease MESH anxiety
disease MESH joint pain
disease MESH weight loss
disease IDO history
disease MESH infection
drug DRUGBANK Indoleacetic acid
disease MESH syndrome
disease MESH clinical progression
disease MESH emergency
drug DRUGBANK Aspartame
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH Complications
drug DRUGBANK Methionine
disease MESH brain fog
disease MESH hair loss
disease MESH rhinitis
disease MESH sore throat
disease MESH chest pain
disease MESH sleep disorders
drug DRUGBANK Tropicamide
disease MESH seizures
disease MESH asthma
pathway KEGG Asthma
disease MESH tic
disease IDO process
drug DRUGBANK Adenosine
disease MESH Functional Status
drug DRUGBANK Oxygen
drug DRUGBANK Etoperidone
disease MESH Morbidity
disease MESH Zona
disease MESH psychological stress
disease MESH symptom burden

Original Article

(Visited 2 times, 1 visits today)